October 27, 2017

October 27, 2017

Must-Read Advice From Black Doctors On Preventing and Battling Cancer

Essence Magazine – Oct. 26
African-Americans have the highest death rate and shortest survival of any racial group in the United States for most cancers. "I tell women that if cancer is more aggressive in Black women, then you have to be more aggressive in taking care of yourself," says B. Lee Green, Jr., Ph.D., vice-president of the Office of Institutional Diversity at the H. Lee Moffitt Cancer Center & Research Institute in Tampa.

 

$1.5 billion-plus in investment headed for USF area in Tampa

TBO.com – Oct. 26
The investors are the University of South Florida, Moffitt Cancer Center, Florida Hospital Tampa, Busch Gardens and University Mall — the anchors of a 6-year-old nonprofit that started as the Tampa Innovation Alliance and now goes by the name "Tampa's !p." (Think "IP," as in innovation place or intellectual property.)

 

Dr. Ruiz on the HIV-Oncology Clinic Program

OncLive – Oct. 26
Marco Ruiz, MD, associate physician, Moffitt Cancer Center, discusses HIV-Oncology Clinic at the Association of Community Cancer Centers (ACCC) 43rd Annual Meeting.

 

Emory Schley: Santa to brighten Rainbow Springs again

Ocala Star Banner – Oct. 265
“I’ve had more than my share of procedures done over the past few years both locally and out of town. I’ve received excellent care and results at Shands and Moffitt Cancer Center in Tampa. I’ve been traveling to Tampa every 28 days for over five years for treatments; my wife drives. I did have the treatment done here in Ocala before that. My favorite comment is, ‘It’s worth the drive.’ Good luck to you and DB with her operation.”

 

FGFR4 Inhibitor Demonstrates Promising Activity in HCC Subgroup

Targeted Oncology – Oct. 26
“Patients with hepatocellular carcinoma face a very poor prognosis with few therapeutic options,” said lead investigator Richard Kim, MD, associate professor, Moffitt Cancer Center. 

 

How to Choose End of Life Care

WebMD – Oct. 26
Your choices depend on what’s most important to you. Your care should be tailored to your goals and needs, says Bryan McIver, MD, head of the Endocrine Oncology Program at Moffitt Cancer Center in Tampa, FL.

 

FDA approval of Yescarta for treating Non-Hodgkin’s Lymphoma brings personalized immunotherapy to the frontlines of care

Pharma’s Almanac – Oct. 26
“With CAR-T therapy, we are reengineering a patient’s own immune system to detect and kill cancer cells, and the results have been impressive,” said Frederick L. Locke, ZUMA-1 Co-Lead Investigator and Vice Chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy at Moffitt Cancer Center in Tampa, Florida.

Cutting-edge immunotherapy treatment approved for another deadly cancer

Daily Journal – Oct. 26
Kite's "vein-to-vein" turnaround period — from cell extraction to reinfusion — is about 17 days, according to Frederick Locke, an oncologist at Moffitt Cancer Center in Tampa and co-leader of the Kite trial.

We need to prepare for sea-level rise

Florida Trend – Oct. 26
Hillsborough offers great schools (the University of South Florida and the University of Tampa to name just two), full-service hospitals from Tampa General and Florida Hospitals to Moffitt Cancer Center and St. Joseph’s, a sporting culture from the NFL’s Tampa Bay Bucs to the NHL’s Tampa Bay Lightning, and important businesses in technology, law, accounting and more.

 

PRSA Tampa Bay Celebrates Public Relations Excellence Announcing PRestige Award Winners for 2017

Chron.com – Oct. 25
21 PR Campaigns were recognized for outstanding programs and tactics at the 3rd Annual PRestige Awards, with best of show honors going to Moffitt Cancer Center

Hungry Howie’s Pizza Mission

WTSP – Oct. 25
They are making a donation each time a pizza is sold in the month of October, Breast Cancer Awareness month. So for, more than 2 million dollars has been raised and  about 20,000 Tampa Bay area women have received free screenings through a Moffitt Cancer Center partnership. For more information go to www.hungryhowies.com.

10 Signs Of Ovarian Cancer Every Woman Should Know About

Women’s Health – Oct. 25
Obviously, these are all things that can happen with a slew of illnesses or just life in general, but persistence and frequency is important, says Mian M. K. Shahzad, M.D., Ph.D., a gynecologic oncologist at Moffitt Cancer Center.

23 ASTRO Members Awarded Fellows Designation

ASCO Post – Oct. 25
…Peter Anthony Spencer Johnstone, MD, Moffitt Cancer Center, Tampa, Florida

Susan G. Komen Awards Moffitt researcher $450,000 Grant to Study New Treatments for Triple Negative Breast Cancer

Press Release Point – Oct. 25
Moffitt Cancer Center recently announced that Andriy Marusyk, Ph.D was awarded a $450,000 research grant from Susan G. Komen. Marusyk is receiving one of 37 research grants looking into novel treatments for aggressive types of breast cancer. This year Komen is focusing on new treatments and understanding of the most lethal forms and stages of breast cancer.

Increased Survival For Melanoma Brain Metastases

Neurology Advisor – Oct. 25
Sarah Sloot, MD, from Groningen University Medical Center in the Netherlands, and colleagues identified 610 patients with unresectable American Joint Committee on Cancer stage III/IV melanoma who received first-line systemic therapy at Moffitt Cancer Center between 2000 and 2012. Also posted to Gears of Biz.

UF Health to study effects of marijuana on HIV symptoms

WTLV - Oct. 24
Pursuant to Florida Statute 1004,4351, the Coalition for Medical Marijuana Research and Education is established inside the H. Lee Moffitt Cancer Center and Research Institute in Tampa for the purpose of conducting "rigorous scientific research, provide education, disseminate research, and guide policy for the adoption of a statewide policy on ordering and dosing practices for the medical use of marijuana."

Dr. Shah Discusses P53-Mutated Mantle Cell Lymphoma

OncLive – Oct. 24
Bijal D. Shah, MD, medical oncologist, Moffitt Cancer Center, discusses treatment for patients with p53-mutated mantle cell lymphoma (MCL).

RFS Benefit in Melanoma Sustained at 3 Years With Adjuvant Nivolumab/Ipilimumab

Targeted Oncology- Oct. 24
Lead study author Zeynep Eroglu, MD, of Moffitt Cancer Center reported the small 40-patient study results showed a “significant toxicity profile with the use of ipilimumab and nivolumab in the adjuvant setting.

Cancer Cure News 2017: FDA approves another gene modification treatment

Christian Post – Oct. 24
Fortunately, only one treatment has to be given for a run. It's well worth it for patients that "don't have other options," as Dr. Frederick L. Locke, a specialist in blood cancers at the Moffitt Cancer Center in Tampa, described the target patients for the new therapy.

Bucs Rookie Club Teams Up with Metropolitan Ministries

Buccaneers.com – Oct. 24
Next week, the group will visit with patients and families at Moffitt Cancer Center.

2017 Tampa Buccaneers Rookie Class Trick-or-Treat their way through Moffitt Cancer Center

Press Release Point – Oct. 24
Moffitt Cancer Center’s lawn will transform into a makeshift football field where students will get a chance to tackle, score touchdowns and throw a football thanks to the NFL’s “Play 60” equipment provided by the Buccaneers.    

FDA Approves Another Immunotherapy For The Treatment Of A Blood Cancer

Gears of Biz – Oct. 23
Meanwhile, Dr. Frederick L. Locke, a specialist in blood cancers at the Moffitt Cancer Center in Tampa and lead author of the study of the new treatment describes the results as remarkable. They are also excited and think that many patients may need this therapy.

Her Campus USF, Bulls for Moffitt Team Up for Breast Cancer Awareness Month

HerCampus.com – Oct. 23
In honor of Breast Cancer Awareness Month, Her Campus USF and Bulls for Moffitt collaborated on a fundraiser to raise money for Moffitt Cancer Center, as well as to educate USF on the dangers of breast cancer.

Kite's CAR T cell therapy Yescarta gets US FDA nod to treat adults with certain types of large B-cell lymphoma

PharmaBiz.com – Oct. 23
"With CAR T therapy, we are reengineering a patient's own immune system to detect and kill cancer cells, and the results have been impressive," said Frederick L. Locke, MD, ZUMA-1 Co-Lead Investigator and Vice Chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy at Moffitt Cancer Center in Tampa, Florida.

 

Timothy Adams Wins Florida Hospital Associations Celebration of Service Award for Trustee of the Year

Press Release Point- Oct. 23
Timothy Adams, chair to Moffitt Cancer Center’s Institute Board of Directors, has won the Celebration of Service Award for Trustee of the Year through the Florida Hospital Association. 

Radionuclide Tx Boosts QoL in Patients with Midgut NETs

MedPage Today – Oct. 22
Compared with patients on a high-dose of somatostatin analog octreotide LAR, patients with midgut neuroendocrine tumors (NETs) given 177Lu reported a significantly longer time to QoL deterioration across several domains, reported Jonathan Strosberg, MD, of Moffitt Cancer Center in Tampa, Florida, and colleagues, in a presentation at the North American Neuroendocrine Tumor Society annual symposium.

 

Adjuvant Nivolumab/Ipilimumab Sustains RFS Benefit in Melanoma at 3 Years

OncLive – Oct. 21
However, the results of the small 40-patient study showed a “significant toxicity profile with the use of ipilimumab and nivolumab in the adjuvant setting,” according to lead author Zeynep Eroglu, MD, Moffitt Cancer Center. 

D.C. Week: Can Congress Agree on an Obamacare Fix?

MedPage Today – Oct. 21
More than 10,000 patients die of DLBCL each year, and axi-cel could have an almost immediate impact on that mortality, said Frederick Locke, MD, of Moffitt Cancer Center in Tampa, Florida.

Black women enlightened By A Group About Breast Cancer

YourBlackWorld.net – Oct. 21
Also, African-American women tend to have higher death rates from breast cancer, said Dr. Danielle Henry, who does breast surgical oncology at Moffitt Cancer Center. “They tend to have a triple-A negative meaning the receptors are negative, and these cancers we know are more aggressive,” she said. 

Coming soon at two Tampa Bay area hospitals: a cancer treatment that could replace chemo

Tampa Bay Times – Oct. 20
Johns Hopkins All Children's Hospital in St. Petersburg will be the first and only pediatric hospital in Florida to become a certified treatment center. Moffitt Cancer Center in Tampa also will be among the first in the country to offer the same therapy on adults with blood cancers like B cell lymphoma.

Gene Therapy: Latest CAR-T Therapy for Cancer Signals New Era for Life-Saving Treatments

Newsweek – Oct. 20
One of those hospitals will be Moffitt Cancer Center in Tampa, Florida. The center treated some of the patients in the clinical trials that supported Yescarta’s approval. Also posted on Yahoo! News.

Group helps increase breast cancer awareness among African-American women

WTSP – Oct. 20
In addition, African-American women tend to have higher death rates from breast cancer, said Dr. Danielle Henry, who does breast surgical oncology at Moffitt Cancer Center.

FDA approves another immunotherapy for the treatment of a blood cancer

Inquisitr – Oct. 20
Meanwhile, Dr. Frederick L. Locke, a specialist in blood cancers at the Moffitt Cancer Center in Tampa and lead author of the study of the new treatment describes the results as remarkable. They are also excited and think that many patients may need this therapy.

‘Revolution in cancer medicine’: KU joins fight with approval of this therapy

Kansas City Star – Oct. 20
List of Sites: Moffitt Cancer Center; Tampa, Fla.

IASLC 2017: Non–Small Cell Lung Cancer Survival Rates Higher Among Patients Treated at Academic Centers

ASCO Post – Oct. 20
Bhagirathbhai Dholaria, MD, of the Moffitt Cancer Center, presented these findings at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) in Yokohama, Japan.

 

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.